| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 21 |
| 1 | ALBUTEROL SULFATE | 19 |
| 2 | PREDNISONE | 18 |
| 3 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 17 |
| 4 | VALSARTAN | 16 |
| 5 | AZATHIOPRINE | 15 |
| 6 | SILDENAFIL | 15 |
| 7 | SILDENAFIL CITRATE | 15 |
| 8 | VALSARTAN ORAL | 15 |
| 9 | CANDESARTAN | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIDOCAINE, PRILOCAINE | 1 | 0.0050 |
| 1 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 1 | 0.0010 |
| 2 | AZATHIOPRINE SODIUM | 2 | 0.0008 |
| 3 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 1 | 0.0005 |
| 4 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| 5 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 6 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| 7 | CANDESARTAN | 14 | 0.0004 |
| 8 | ARTIFICIAL TEARS | 1 | 0.0004 |
| 9 | POLYVINYL ALCOHOL, POVIDONE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 22 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 2 | Expectorant [EPC] | 17 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 16 |
| 4 | Purine Antimetabolite [EPC] | 16 |
| 5 | Atypical Antipsychotic [EPC] | 9 |
| 6 | Vitamin B12 [EPC] | 7 |
| 7 | Vitamin C [EPC] | 6 |
| 8 | Azole Antifungal [EPC] | 5 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 1 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 2 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 6 | Purine Antimetabolite [EPC] | 16 | 0.0002 |
| 7 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 9 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |